Estrella Immunopharma, Inc. (ESLAW) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $3.18M | +1.2% |
| 2024 | $3.14M | +3.7% |
| 2023 | $3.03M | -68.9% |
| 2022 | $9.72M | -78.8% |
| 2021 | $45.80M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $3.18M | +1.2% |
| 2024 | $3.14M | +3.7% |
| 2023 | $3.03M | -68.9% |
| 2022 | $9.72M | -78.8% |
| 2021 | $45.80M | — |